Citation Impact
Citing Papers
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy?
2000
Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO2slope and peak VO2
2000
Kinetics of oxygen consumption during and after exercise in patients with dilated cardiomyopathy New markers of exercise intolerance with clinical implications
1996
Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure
1992
Physical training in patients with stable chronic heart failure: Effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles
1995
Evaluation of Diastolic Filling of Left Ventricle in Health and Disease: Doppler Echocardiography Is the Clinician’s Rosetta Stone
1997
Myasthenia Gravis
2016 Standout
Effect of Intravenous Iron Sucrose on Exercise Tolerance in Anemic and Nonanemic Patients With Symptomatic Chronic Heart Failure and Iron Deficiency
2008
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
1996 Standout
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20% secondary to ischemic or nonischemic dilated cardiomyopathy
1990
The Failing Heart — An Engine Out of Fuel
2007 Standout
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance
1990
Ventilatory Efficiency and Resting Hemodynamics in Hypertrophic Cardiomyopathy
2008
Prognosis of congestive heart failure and predictors of mortality
1988
Serial exercise testing and prognosis in selected patients considered for cardiac transplantation
1998
The right ventricle: anatomy, physiology, and clinical importance
1991
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
1990 Standout
A Randomized, Controlled Trial of the Use of Pulmonary-Artery Catheters in High-Risk Surgical Patients
2003 Standout
Withdrawal of Digoxin from Patients with Chronic Heart Failure Treated with Angiotensin-Converting-Enzyme Inhibitors
1993
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
CHRONIC AORTIC REGURGITATION
1998
Chronic Aortic Regurgitation: Indications for Operation—1988
1988
Insulin Resistance in Chronic Heart Failure: Relation to Severity and Etiology of Heart Failure
1997
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
1991 Standout
Normalization of cardiac structure and function after regression of cardiac hypertrophy
1994
Effect of quinapril on blood pressure and heart rate in congestive heart failure
1992
Lisinopril in the Treatment of Congestive Heart Failure in Elderly Patients: Comparison versus Captopril
1997
Prognostic Significance and Measurement of Exercise-Derived Hemodynamic Variables in Patients With Heart Failure
2007
Left ventricular long-axis function in myasthenia gravis
2008
Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy∗∗∗∗A list of participating hospitals, central agencies and personnel appears in reference 26.
2000
Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: The Hy-C trial
1992
Elastic sealants for surgical applications
2015
Long-Term Vasodilator Therapy in Patients with Severe Aortic Regurgitation
2005
Effects of Endurance Training on Mitochondrial Ultrastructure and Fiber Type Distribution in Skeletal Muscle of Patients With Stable Chronic Heart Failure
1997
Angiotensin‐converting enzyme inhibition and physical training in heart failure
1991
Cardiopulmonary Exercise Testing Identifies Low Risk Patients With Heart Failure and Severely Impaired Exercise Capacity Considered for Heart Transplantation
1998
Contribution of peak respiratory exchange ratio to peak VO2 prognostic reliability in patients with chronic heart failure and severely reduced exercise capacity
2003
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope
2005
Comparison of single-dose nifedipine and captopril for chronic severe aortic regurgitation
1993
Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure
1993
The Six-Minute Walk Test Predicts Peak Oxygen Uptake and Survival in Patients With Advanced Heart Failure
1996
Cardiac Resynchronization in Chronic Heart Failure
2002 Standout
The Clinical Course of Pulmonary Embolism
1992 Standout
Myocarditis
2011 Standout
Heart failure management: The impact of drug therapy on survival
1988
Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure
1995
Prognostic Importance of Elevated Jugular Venous Pressure and a Third Heart Sound in Patients with Heart Failure
2001 Standout
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
Nifedipine in Asymptomatic Patients with Severe Aortic Regurgitation and Normal Left Ventricular Function
1994
Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction
1993
A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure
1991 Standout
Effects of Gender on Peak Oxygen Consumption and the Timing of Cardiac Transplantation
2006
Ease of Noninvasive Measurement of Cardiac Output Coupled With Peak VO2 Determination at Rest and During Exercise in Patients With Heart Failure
2006
Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure
1998
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Burden of valvular heart diseases: a population-based study
2006 Standout
Relationship between left ventricular wall thickness and left atrial size: Comparison with other measures of diastolic function
1995
Dry double-sided tape for adhesion of wet tissues and devices
2019 StandoutNature
Clinical outcome of severe asymptomatic chronic aortic regurgitation: A long-term prospective follow-up study
1995
Managing Asymptomatic Patients With Chronic Aortic Regurgitation
1997
Short- and long-acting angiotensin-converting enzyme inhibitors: A randomized trial of lisinopril versus captopril in the treatment of congestive heart failure
1989
Antihypertensive treatment in hypertensive patients with normal left ventricular mass is associated with left ventricular remodeling and improved diastolic function
1996
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
1997 Standout
Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure
1999
Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy
1996
Vasodilation with felodipine in chronic asymptomatic aortic regurgitation
2000
Mechanisms, diagnosis, and treatment of diastolic heart failure
1995
Ventilatory mechanisms of exercise intolerance in chronic heart failure
1992
Long-term nifedipine unloading therapy in asymptomatic patients with chronic severe aortic regurgitation
1990
Vasodilator therapy in chronic asymptomatic aortic regurgitation: Enalapril versus hydralazine therapy
1994
Clinical Perspectives
1998
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
2007 Standout
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hope
1988
Comparison of ST segment depression in upright treadmill and supine bicycle exercise testing
1988
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
1992 Standout
Effects of exercise training in patients with congestive heart failure: A critical review
1995
Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood
1991 Standout
Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves
1996
Chronic Aortic Insufficiency: Factors Associated with Progression to Aortic Valve Replacement
1989
Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy
1994
Implications of chronic heart failure on peripheral vasculature and skeletal muscle before and after exercise training
2007
A prospectus on tissue adhesives
2001
Exercise limitation in chronic heart failure: Central role of the periphery
1996
Biomarkers in Heart Failure
2008 Standout
Burden of Systolic and Diastolic Ventricular Dysfunction in the Community
2003 Standout
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
What is the ideal study design for evaluation of treatment for heart failure?: Insights from trials assessing the effect of ACE inhibitors on exercise capacity
1996
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
2002 Standout
Myocarditis
2009 Standout
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Guidelines for clinical use of cardiac radionuclide imaging report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Society of Nuclear Cardiology
1995
Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.
1995
Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure
1984
Functional Renal Insufficiency During Long-Term Therapy with Captopril and Enalapril in Severe Chronic Heart Failure
1987
Differences in generalist and specialist physicians’ knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure
1997
Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial.
1985
Afterload reduction: a comparison of captopril and nifedipine in dilated cardiomyopathy.
1986
Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy
2000 Standout
Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects.
1987
Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.
1989
Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.
1985
The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure
1997 Standout
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Recommendations on the use of exercise testing in clinical practice
2006
Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy
1987
Peak Cardiac Power Output, Measured Noninvasively, Is a Powerful Predictor of Outcome in Chronic Heart Failure
2009
Recommendations concerning use of echocardiography in hypertension and general population research.
1987
Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
2003
Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.
1985
The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension.
1985
Prediction of Indications for Valve Replacement Among Asymptomatic or Minimally Symptomatic Patients With Chronic Aortic Regurgitation and Normal Left Ventricular Performance
1998
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Survival and functional results after valve replacement for aortic regurgitation from 1976 to 1983: impact of preoperative left ventricular function.
1985
Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure.
1986
Comparative hemodynamic and clinical effects of long-term treatment with prazosin and captopril for severe chronic congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy
1986
Exercise Capacity and Mortality among Men Referred for Exercise Testing
2002 Standout
Clinical, Hemodynamic, and Cardiopulmonary Exercise Test Determinants of Survival in Patients Referred for Evaluation of Heart Failure
1998
Comparison of Captopril and Enalapril in Patients with Severe Chronic Heart Failure
1986
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Designing Cell-Compatible Hydrogels for Biomedical Applications
2012 StandoutScience
Relative Efficacy of Vasodilator Therapy in Chronic Congestive Heart Failure
1988
Chronic heart failure in the elderly: value of cardiopulmonary exercise testing in risk stratification
2000
Development and Prospective Validation of a Clinical Index to Predict Survival in Ambulatory Patients Referred for Cardiac Transplant Evaluation
1997
Influence of chronic captopril therapy on the infarcted left ventricle of the rat.
1985
Heart Rate Variability
1996 Standout
Heart rate variability: Standards of measurement, physiological interpretation, and clinical use
1996 Standout
Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.
1984
Diastolic Dysfunction in Hypertensive Heart Disease Is Associated With Altered Myocardial Metabolism
1999
Experience with the Preoperative Invasive Measurement of Haemodynamic, Respiratory and Renal Function in 100 Elderly Patients Scheduled for Major Abdominal Surgery
1988
Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow.
1988
Congestive Heart Failure With Normal Left Ventricular Systolic Function
1996
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Angiotensin Receptor Blockade and Exercise Capacity in Adults With Systemic Right Ventricles
2005
Captopril in heart failure. A double blind controlled trial.
1984
Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure
1984
Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure.
1985
Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.
1984
The role of right and left ventricular function in the ventilatory response to exercise in chronic heart failure.
1994
Hemodynamic Exercise Testing
1996
Myocardial Phosphocreatine-to-ATP Ratio Is a Predictor of Mortality in Patients With Dilated Cardiomyopathy
1997
Works of Nina Topic being referenced
Controlled clinical trial of a novel hemostatic agent in cardiac surgery
2000
Long-term vasodilator therapy of chronic aortic insufficiency. A randomized double-blinded, placebo-controlled clinical trial.
1988
Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.
1983
Ejection fraction response to supine exercise in asymptomatic aortic regurgitation: Relation to simultaneous hemodynamic measurements
1985
Acute and long‐term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.
1982
Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure
1982
Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure
1985
Long-term captopril therapy for chronic congestive heart failure
1984
Hemodynamic and radionuclide effects of acute captopril therapy for heart failure: changes in left and right ventricular volumes and function at rest and during exercise.
1982
Abnormal left ventricular filling: An early finding in mild to moderate systemic hypertension
1984
Correlates and prognostic implication of exercise capacity in chronic congestive heart failure
1985
Hemodynamic differences between supine and upright exercise in patients with congestive heart failure.
1982
Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses.
1984